This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lo, E. H. Articles by Moskowitz, M. A. Search for Related Content PubMed PubMed Citation Articles by Lo, E. H. Articles by Moskowitz, M. A.

(Stroke. 2004;35:354.)
© 2004 American Heart Association, Inc.

Advances in Stroke 2003

tPA and Proteolysis in the Neurovascular Unit

Eng H. Lo, PhD; Joseph P. Broderick, MD Michael A. Moskowitz, MD

From the Neuroprotection Research Laboratory (E.H.L.), Departments of Radiology and Neurology, Massachusetts General Hospital, and Program in Neuroscience, Harvard Medical School, Charlestown, Mass; Department of Neurology (J.P.B.), University of Cincinnati, Cincinnati, Ohio; and Neurovascular Regulation and Stroke Laboratory (M.A.M.), Departments of Radiology and Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Charlestown, Mass.

Correspondence to Eng H. Lo, Neuroprotection Research Laboratory, Harvard Medical School, MGH East 149-2401, Charlestown, MA 02129. E-mail Lo@helix.mgh.harvard.edu

Key Words: Advances in Stroke • blood-brain barrier • matrix metalloproteinase • proteolysis • reperfusion injury • tissue plasminogen activator

An extract of the first 250 words of the full text is provided, because this article has no abstract.

One of the major recommendations emerging from the NINDS Stroke Progress Review Group was to shift the emphasis from a purely neurocentric view of cell death toward a more integrative approach whereby responses in all brain cells and matrix are considered during cerebral ischemia (see Figure). The concept of the neurovascular unit (fundamentally comprising endothelium, astrocyte, and neuron) provides a modular framework where cell-cell signaling and cell-matrix interactions mediate the overall tissue response to stroke and its treatments.¹ There is no doubt that reperfusing blood vessels mechanically or pharmacologically prevents cell death and rescues brain when performed in a timely manner, as it does in ischemic myocardium. However, under some circumstances, thrombolysis and reperfusion lead to cerebral hemorrhage and edema. Here, we examine the hypothesis that beneficial versus potentially deleterious outcomes after tissue plasminogen activator (tPA) stroke therapy may relate in part to matrix proteolysis within the neurovascular unit, and review recent advances in this area.

View larger version (16K): [in this window] [in a new window]   Schematic of the basic neurovascular unit showing functional interactions between neuron, astrocyte, and cerebral endothelium. This conceptual construct provides a framework for investigating the integrative response of brain to stroke and therapy. Note: ultimately, all cell types should be considered including smooth muscle cells, pericytes, as well as oligodendrocytes and axons in white matter.

tPA: More Than Clot Lysis

More than 7 years after the major ECASS and NINDS trials,^2,3 use of tPA therapy remains limited.⁴ In part, this may be due to narrow time-to-treatment windows and apparent complications of hemorrhage and brain injury.⁵ The primary action of . . . [Full Text of this Article]

This article has been cited by other articles:

				D. Yang, N. Nemkul, A. Shereen, A. Jone, R. S. Dunn, D. A. Lawrence, D. Lindquist, and C.-Y. Kuan Therapeutic Administration of Plasminogen Activator Inhibitor-1 Prevents Hypoxic-Ischemic Brain Injury in Newborns J. Neurosci., July 8, 2009; 29(27): 8669 - 8674. [Abstract] [Full Text] [PDF]

				W. Liu, J. Hendren, X.-J. Qin, and K. J. Liu Normobaric Hyperoxia Reduces the Neurovascular Complications Associated With Delayed Tissue Plasminogen Activator Treatment in a Rat Model of Focal Cerebral Ischemia Stroke, July 1, 2009; 40(7): 2526 - 2531. [Abstract] [Full Text] [PDF]

				A. Reijerkerk, G. Kooij, S. M. A. van der Pol, T. Leyen, B. van het Hof, P.-O. Couraud, D. Vivien, C. D. Dijkstra, and H. E. de Vries Tissue-Type Plasminogen Activator Is a Regulator of Monocyte Diapedesis through the Brain Endothelial Barrier J. Immunol., September 1, 2008; 181(5): 3567 - 3574. [Abstract] [Full Text] [PDF]

				A. Reshef, A. Shirvan, R. N. Waterhouse, H. Grimberg, G. Levin, A. Cohen, L. G. Ulysse, G. Friedman, G. Antoni, and I. Ziv Molecular Imaging of Neurovascular Cell Death in Experimental Cerebral Stroke by PET J. Nucl. Med., September 1, 2008; 49(9): 1520 - 1528. [Abstract] [Full Text] [PDF]

				O. Moldes, T. Sobrino, M. Millan, M. Castellanos, N. Perez de la Ossa, R. Leira, J. Serena, J. Vivancos, A. Davalos, and J. Castillo High Serum Levels of Endothelin-1 Predict Severe Cerebral Edema in Patients With Acute Ischemic Stroke Treated With t-PA Stroke, July 1, 2008; 39(7): 2006 - 2010. [Abstract] [Full Text] [PDF]

				F. Adhami, D. Yu, W. Yin, A. Schloemer, K. A. Burns, G. Liao, J. L. Degen, J. Chen, and C.-Y. Kuan Deleterious Effects of Plasminogen Activators in Neonatal Cerebral Hypoxia-Ischemia Am. J. Pathol., June 1, 2008; 172(6): 1704 - 1716. [Abstract] [Full Text] [PDF]

				S. Guo, W. J. Kim, J. Lok, S.-R. Lee, E. Besancon, B.-H. Luo, M. F. Stins, X. Wang, S. Dedhar, and E. H. Lo Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons PNAS, May 27, 2008; 105(21): 7582 - 7587. [Abstract] [Full Text] [PDF]

				G. A. Donnan The 2007 Feinberg Lecture: A New Road Map for Neuroprotection Stroke, January 1, 2008; 39(1): 242 - 242. [Abstract] [Full Text] [PDF]

				S. Hom, M. A. Fleegal, R. D. Egleton, C. R. Campos, B. T. Hawkins, and T. P. Davis Comparative changes in the blood-brain barrier and cerebral infarction of SHR and WKY rats Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2007; 292(5): R1881 - R1892. [Abstract] [Full Text] [PDF]

				J. P. Lopez-Atalaya, B. D. Roussel, C. Ali, E. Maubert, K.-U. Petersen, V. Berezowski, R. Cecchelli, C. Orset, and D. Vivien Recombinant Desmodus rotundus Salivary Plasminogen Activator Crosses the Blood-Brain Barrier Through a Low-Density Lipoprotein Receptor-Related Protein-Dependent Mechanism Without Exerting Neurotoxic Effects Stroke, March 1, 2007; 38(3): 1036 - 1043. [Abstract] [Full Text] [PDF]

				B.-Q. Zhao, E. Tejima, and E. H. Lo Neurovascular Proteases in Brain Injury, Hemorrhage and Remodeling After Stroke Stroke, February 1, 2007; 38(2): 748 - 752. [Abstract] [Full Text] [PDF]

				M. Millan, T. Sobrino, M. Castellanos, F. Nombela, J. F. Arenillas, E. Riva, I. Cristobo, M. M. Garcia, J. Vivancos, J. Serena, et al. Increased Body Iron Stores Are Associated With Poor Outcome After Thrombolytic Treatment in Acute Stroke Stroke, January 1, 2007; 38(1): 90 - 95. [Abstract] [Full Text] [PDF]

				S. Wang, S.-R. Lee, S.-Z. Guo, W. J. Kim, J. Montaner, X. Wang, and E. H. Lo Reduction of Tissue Plasminogen Activator-Induced Matrix Metalloproteinase-9 by Simvastatin in Astrocytes Stroke, July 1, 2006; 37(7): 1910 - 1912. [Abstract] [Full Text] [PDF]

				M. Ning, K. L. Furie, W. J. Koroshetz, H. Lee, M. Barron, M. Lederer, X. Wang, M. Zhu, A. G. Sorensen, E. H. Lo, et al. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke Neurology, May 23, 2006; 66(10): 1550 - 1555. [Abstract] [Full Text] [PDF]

				S.-R. Lee, H.-Y. Kim, J. Rogowska, B.-Q. Zhao, P. Bhide, J. M. Parent, and E. H. Lo Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke. J. Neurosci., March 29, 2006; 26(13): 3491 - 3495. [Abstract] [Full Text] [PDF]

				Z. G. Zhang, L. Zhang, G. Ding, Q. Jiang, R. L. Zhang, X. Zhang, W.-B. Gan, and M. Chopp A Model of Mini-Embolic Stroke Offers Measurements of the Neurovascular Unit Response in the Living Mouse Stroke, December 1, 2005; 36(12): 2701 - 2704. [Abstract] [Full Text] [PDF]

				M. A. Fleegal, S. Hom, L. K. Borg, and T. P. Davis Activation of PKC modulates blood-brain barrier endothelial cell permeability changes induced by hypoxia and posthypoxic reoxygenation Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2012 - H2019. [Abstract] [Full Text] [PDF]

				K. Tsuji, T. Aoki, E. Tejima, K. Arai, S.-R. Lee, D. N. Atochin, P. L. Huang, X. Wang, J. Montaner, and E. H. Lo Tissue Plasminogen Activator Promotes Matrix Metalloproteinase-9 Upregulation After Focal Cerebral Ischemia Stroke, September 1, 2005; 36(9): 1954 - 1959. [Abstract] [Full Text] [PDF]

				B. T. Hawkins and T. P. Davis The Blood-Brain Barrier/Neurovascular Unit in Health and Disease Pharmacol. Rev., June 1, 2005; 57(2): 173 - 185. [Abstract] [Full Text] [PDF]

				D. Hanley and W. Hacke Critical Care and Emergency Medicine Neurology in Stroke Stroke, February 1, 2005; 36(2): 205 - 207. [Full Text] [PDF]

				M. Yepes and D. A. Lawrence New Functions for an Old Enzyme: Nonhemostatic Roles for Tissue-Type Plasminogen Activator in the Central Nervous System Experimental Biology and Medicine, December 1, 2004; 229(11): 1097 - 1104. [Abstract] [Full Text] [PDF]

				X. Wang, K. Tsuji, S.-R. Lee, M. Ning, K. L. Furie, A. M. Buchan, and E. H. Lo Mechanisms of Hemorrhagic Transformation After Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke Stroke, November 1, 2004; 35(11_suppl_1): 2726 - 2730. [Abstract] [Full Text] [PDF]

				R. A. Adams, M. Passino, B. D. Sachs, T. Nuriel, and K. Akassoglou Fibrin Mechanisms and Functions in Nervous System Pathology Mol. Interv., June 1, 2004; 4(3): 163 - 176. [Abstract] [Full Text] [PDF]